R16	Appositive Attribute:T193 Head:T33
R17	Appositive Attribute:T208 Head:T50
R18	Anaphora Anaphor:T162 Antecedent:T150
R19	Anaphora Anaphor:T178 Antecedent:T168
R20	Anaphora Anaphor:T183 Antecedent:T154
R21	Anaphora Anaphor:T297 Antecedent:T142
R22	Anaphora Anaphor:T306 Antecedent:T143
R23	Anaphora Anaphor:T301 Antecedent:T144
R24	Anaphora Anaphor:T303 Antecedent:T301
T7	Drug_Class 221 240	calcium antagonists
T6	Drug 196 208	- Felodipine
T20	Drug_Class 863 875	beta blocker
T17	Drug 752 759	PLENDIL
T5	Drug_Class 2373 2390	CYP3A4 inhibitors
T29	Drug 2396 2408	ketoconazole
T30	Drug 2410 2422	itraconazole
T9	Drug 2424 2436	erythromycin
T11	Substance 2438 2454	grapefruit juice
T31	Drug 2456 2466	cimetidine
T15	Drug 2543 2553	felodipine
T34	Drug_Class 2824 2847	potent CYP3A4 inhibitor
T33	Drug 2808 2820	itraconazole
T38	Drug 2921 2931	felodipine
T37	Drug_Class 2878 2895	CYP3A4 inhibitors
T47	Drug 3293 3303	felodipine
T41	Drug 3143 3155	itraconazole
T40	Drug 3095 3137	extended release formulation of felodipine
T51	Drug 3367 3379	erythromycin
T72	Drug 3495 3505	felodipine
T74	Substance 3563 3579	grapefruit juice
T73	Drug 3679 3689	felodipine
T89	Drug_Class 3755 3785	non-specific CYP-450 inhibitor
T50	Drug 3741 3751	cimetidine
T95	Drug 3860 3870	felodipine
T104	Drug 4027 4037	felodipine
T101	Drug 4059 4069	metoprolol
T57	Drug_Class 4175 4188	beta blockers
T58	Drug 4199 4209	metoprolol
T66	Drug 4504 4514	felodipine
T68	Drug_Class 4574 4588	anticonvulsant
T69	Drug 4604 4613	phenytoin
T70	Drug 4615 4628	carbamazepine
T71	Drug 4633 4646	phenobarbital
T107	Drug 4718 4728	felodipine
T77	Drug 5042 5052	tacrolimus
T76	Drug 4989 5001	- Felodipine
T78	Drug 5084 5094	felodipine
T79	Drug 5100 5110	tacrolimus
T111	Drug 5158 5168	tacrolimus
T112	Substance 3507 3525	Grapefruit juice -
T113	Drug_Class 3872 3894	Beta-Blocking Agents -
T114	Drug_Class 2295 2314	CYP3A4 Inhibitors -
T115	Drug_Class 4913 4937	antihypertensive therapy
T116	Drug 4282 4291	Digoxin -
T117	Drug 4354 4361	digoxin
T118	Drug 5358 5372	spironolactone
T119	Drug 3691 3703	Cimetidine -
T120	Drug 3051 3065	Itraconazole -
T121	Drug 3953 3963	metoprolol
T122	Drug 3305 3319	Erythromycin -
T123	Drug 5342 5354	indomethacin
T124	Drug 46 56	Felodipine
T125	Drug 576 586	felodipine
T126	Drug 998 1008	felodipine
T127	Drug 2315 2325	Felodipine
T128	Drug 2473 2483	felodipine
T129	Drug 2967 2977	felodipine
T130	Drug 3341 3351	felodipine
T131	Drug 3547 3557	felodipine
T132	Drug 3725 3735	felodipine
T133	Drug 3922 3932	felodipine
T134	Drug 4246 4256	felodipine
T135	Drug 5302 5312	felodipine
T136	Drug 5559 5569	felodipine
T137	Drug 6013 6023	Felodipine
T138	Drug 6741 6751	Felodipine
T139	Drug 6949 6959	Felodipine
T140	Drug 7533 7543	felodipine
T141	Drug 8224 8234	felodipine
T142	Drug 9139 9149	felodipine
T143	Drug 9367 9377	felodipine
T144	Drug 9589 9599	felodipine
T145	Drug 9889 9899	felodipine
T146	Drug 10215 10225	felodipine
T147	Drug 4978 4988	Tacrolimus
T149	Drug 26 33	PLENDIL
T150	Drug 80 87	PLENDIL
T151	Drug 1043 1050	PLENDIL
T152	Drug 1210 1217	PLENDIL
T153	Drug 1826 1833	PLENDIL
T154	Drug 2099 2106	PLENDIL
T155	Drug 3353 3360	PLENDIL
T156	Drug 4322 4329	PLENDIL
T315	SPAN 184 195	Hypotension
T316	SPAN 1788 1796	Patients
T317	SPAN 1963 1982	Good dental hygiene
T318	SPAN 9916 9934	sufficient numbers
T160	ZeroArticleNP 0 10	Drug Label
T161	ZeroArticleNP 15 33	drug brand PLENDIL
T162	DemonstrativeNP 145 157	this product
T163	IndefiniteNP 215 240	other calcium antagonists
T164	PersonalPronoun 317 319	It
T165	IndefiniteNP 496 510	a small number
T166	ZeroArticleNP 528 541	NYHA Class II
T167	IndefiniteNP 861 875	a beta blocker
T168	ZeroArticleNP 844 855	combination
T169	IndefiniteNP 1063 1078	a starting dose
T170	IndefiniteNP 1094 1099	a day
T171	PossessivePronoun 1143 1163	their blood pressure
T172	DemonstrativeNP 1116 1130	These patients
T173	DefiniteNP 1387 1416	the most common adverse event
T174	DefiniteNP 1420 1439	the clinical trials
T175	DefiniteNP 1441 1454	The incidence
T176	DefiniteNP 1732 1746	the initiation
T177	DemonstrativeNP 1675 1694	This adverse effect
T178	DefiniteNP 1865 1876	the tablets
T179	PersonalPronoun 1878 1882	They
T180	PossessivePronoun 1993 2006	its incidence
T181	DefiniteNP 2160 2186	the safe and effective use
T182	DemonstrativeNP 2121 2137	This information
T183	DemonstrativeNP 2190 2205	this medication
T184	PersonalPronoun 2207 2209	It
T185	IndefiniteNP 2217 2229	a disclosure
T186	ZeroArticleNP 2295 2314	CYP3A4 Inhibitors -
T187	DistributivePronoun 2555 2561	either
T188	DefiniteNP 2522 2539	the plasma levels
T189	IndefiniteNP 2569 2580	an increase
T190	IndefiniteNP 2610 2620	a decrease
T191	ZeroArticleNP 2373 2390	CYP3A4 inhibitors
T192	DemonstrativeNP 2636 2651	These increases
T193	IndefiniteNP 2822 2847	a potent CYP3A4 inhibitor
T194	DemonstrativeNP 2749 2762	These effects
T195	ZeroArticleNP 2878 2895	CYP3A4 inhibitors
T196	IndefiniteNP 2933 2956	A conservative approach
T197	DefiniteNP 2995 3030	The following specific interactions
T198	DefiniteNP 3201 3208	the AUC
T199	DefiniteNP 3239 3247	the Cmax
T200	DefiniteNP 3276 3289	the half-life
T201	IndefiniteNP 3087 3137	another extended release formulation of felodipine
T202	DefiniteNP 3427 3434	the AUC
T203	DefiniteNP 3478 3491	the half-life
T204	DefiniteNP 3621 3628	the AUC
T205	DefiniteNP 3662 3675	the half-life
T206	DefiniteNP 3835 3842	the AUC
T207	DefiniteNP 3847 3855	the Cmax
T208	IndefiniteNP 3753 3785	a non-specific CYP-450 inhibitor
T209	IndefiniteNP 3799 3810	an increase
T210	DefiniteNP 4003 4023	the pharmacokinetics
T211	IndefiniteNP 3895 3918	A pharmacokinetic study
T212	ZeroArticleNP 3872 3894	Beta-Blocking Agents -
T213	DefiniteNP 4039 4046	The AUC
T214	ZeroArticleNP 4175 4188	beta blockers
T215	DefiniteNP 4330 4350	the pharmacokinetics
T216	IndefiniteNP 4446 4469	a pharmacokinetic study
T217	ZeroArticleNP 4564 4596	long-term anticonvulsant therapy
T218	DefiniteNP 4694 4707	the mean area
T219	DefiniteNP 4714 4760	the felodipine plasma concentration-time curve
T220	DemonstrativeNP 4679 4692	such patients
T221	IndefiniteNP 4844 4880	a clinically significant interaction
T222	DemonstrativeNP 4962 4976	these patients
T223	ZeroArticleNP 4901 4937	alternative antihypertensive therapy
T224	DefiniteNP 5015 5038	the blood concentration
T225	DefiniteNP 5096 5130	the tacrolimus blood concentration
T226	DefiniteNP 5154 5173	the tacrolimus dose
T227	IndefiniteNP 5199 5224	Other Concomitant Therapy
T228	DefiniteNP 5659 5670	the maximum
T229	DefiniteNP 5740 5753	the incidence
T230	DefiniteNP 5792 5802	the testes
T231	IndefiniteNP 5516 5546	a 2-year carcinogenicity study
T232	IndefiniteNP 5697 5710	a mg/m2 basis
T233	IndefiniteNP 5713 5736	a dose-related increase
T234	DefiniteNP 5959 5970	the maximum
T235	IndefiniteNP 5893 5908	a similar study
T236	IndefiniteNP 5997 6010	a mg/m2 basis
T237	DemonstrativeNP 5859 5871	These tumors
T238	DefiniteNP 6028 6037	the doses
T239	DefiniteNP 6050 6070	the 2-year rat study
T240	IndefiniteNP 6135 6159	a corresponding increase
T241	DefiniteNP 6198 6231	The Leydig cell tumor development
T242	DemonstrativeNP 6257 6279	these hormonal effects
T243	DefiniteNP 6367 6380	the incidence
T244	DefiniteNP 6452 6473	the esophageal groove
T245	IndefiniteNP 6340 6363	a dose-related increase
T246	IndefiniteNP 6501 6516	all dose groups
T247	DemonstrativeNP 6320 6339	this same rat study
T248	DefiniteNP 6588 6596	the rats
T249	DefiniteNP 6646 6664	The latter species
T250	DefiniteNP 6718 6739	the esophageal groove
T251	DefiniteNP 6832 6843	the maximum
T252	IndefiniteNP 6870 6883	a mg/m2 basis
T253	DefiniteNP 7011 7047	the Ames microbial mutagenicity test
T254	DefiniteNP 7054 7072	the mouse lymphoma
T255	IndefiniteNP 6976 6998	any mutagenic activity
T256	DefiniteNP 7142 7169	the mouse micronucleus test
T257	DefiniteNP 7214 7225	the maximum
T258	IndefiniteNP 7252 7265	a mg/m2 basis
T259	IndefiniteNP 7282 7328	a human lymphocyte chromosome aberration assay
T260	DefiniteNP 7448 7459	the maximum
T261	IndefiniteNP 7330 7347	A fertility study
T262	IndefiniteNP 7486 7499	a mg/m2 basis
T263	DefiniteNP 7737 7748	the maximum
T264	DefiniteNP 7877 7899	the terminal phalanges
T265	DefiniteNP 7903 7914	the fetuses
T266	IndefiniteNP 7775 7788	a mg/m2 basis
T267	DefiniteNP 7916 7929	The frequency
T268	DefiniteNP 7946 7957	the changes
T269	DefiniteNP 8003 8018	the lowest dose
T270	DefiniteNP 8081 8106	the dihydropyridine class
T271	IndefiniteNP 8064 8077	other members
T272	IndefiniteNP 8124 8132	a result
T273	DemonstrativeNP 8020 8033	These changes
T274	DefiniteNP 8297 8305	the size
T275	DefiniteNP 8309 8331	the terminal phalanges
T276	DefiniteNP 8374 8394	the distal phalanges
T277	DefiniteNP 8421 8432	the fetuses
T278	IndefiniteNP 8239 8257	a teratology study
T279	IndefiniteNP 8350 8370	an abnormal position
T280	DefiniteNP 8642 8664	the maximum human dose
T281	IndefiniteNP 8460 8474	A prolongation
T282	IndefiniteNP 8515 8537	an increased frequency
T283	IndefiniteNP 8668 8681	a mg/m2 basis
T284	DefiniteNP 8722 8740	the mammary glands
T285	DefiniteNP 8755 8777	the normal enlargement
T286	DefiniteNP 8871 8893	the maximum human dose
T287	IndefiniteNP 8897 8910	a mg/m2 basis
T288	DemonstrativeNP 8913 8924	This effect
T289	DefiniteNP 9010 9028	the mammary glands
T290	PersonalPronoun 9235 9238	she
T291	DefiniteNP 9182 9193	the patient
T292	DefiniteNP 9261 9281	the potential hazard
T293	DefiniteNP 9285 9294	the fetus
T294	DefiniteNP 9326 9336	the infant
T295	DefiniteNP 9342 9363	the potential effects
T296	DefiniteNP 9407 9425	the mammary glands
T297	DemonstrativeNP 9224 9233	this drug
T298	PersonalPronoun 9465 9467	It
T299	DefiniteNP 9540 9553	the potential
T300	DefiniteNP 9603 9613	the infant
T301	DefiniteNP 9690 9698	the drug
T302	DefiniteNP 9720 9734	the importance
T303	DefiniteNP 9738 9746	the drug
T304	DefiniteNP 9750 9760	the mother
T305	IndefiniteNP 9615 9625	a decision
T306	DemonstrativeNP 9489 9498	this drug
T307	PersonalPronoun 9985 9989	they
T308	DefiniteNP 10120 10131	the elderly
T309	DefiniteNP 10195 10211	the availability
T310	DefiniteNP 10391 10402	the low end
T311	DefiniteNP 10406 10422	the dosing range
T312	DefiniteNP 10435 10456	the greater frequency
T313	IndefiniteNP 10332 10350	an elderly patient
T314	IndefiniteNP 10537 10555	other drug therapy
